AU  - Langman MJ
TI  - ROfecoxib and the risk of adverse upper gastrointestinal effects—reply
PT  - JOUR
DP  - 2000
TA  - JAMA
pages = {1960-1961},
VI  - 283
IP  - 15
AID  - 10.1001/jama.283.15.1957 [doi]
4100  - http://dx.doi.org/10.1001/jama.283.15.1957
SO  - JAMA April 19, 2000 283(15):1960